Literature DB >> 22923184

Ectopic pituitary adenoma with empty sella in the setting of MEN-1 syndrome: detection with 68Ga-DOTANOC PET/CT.

Niraj Naswa1, Chandan Jyoti Das, Punit Sharma, Sellam Karunanithi, Chandrasekhar Bal, Rakesh Kumar.   

Abstract

Patients with multiple endocrine neoplasia type-1 syndromes are known to have neuroendocrine tumors (NETs) involving the pituitary and gastroenteropancreatic region, in addition to the presence of parathyroid abnormalities. In rare instances adenomas in the ectopic pituitary gland have been reported. As pituitary gland and pituitary adenomas are known to express SSTRs, somatostatin receptor scintigraphy can be used for imaging. Somatostatin receptor-based PET/CT imaging using 68Ga-DOTANOC has become a popular noninvasive imaging modality for evaluation of patients with NETs. The application of 68Ga-DOTANOC PET/CT can be extended to multiple endocrine neoplasia type 1 patients, as is evident from this case study.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22923184     DOI： 10.1007/s11604-012-0117-0

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN： 1867-1071            Impact factor:   2.374


  10 in total

Review 1.  Somatostatin receptors in pituitary function, diagnosis and therapy.

Authors:  Leo J Hofland; Steven W J Lamberts
Journal:  Front Horm Res       Date:  2004       Impact factor: 2.606

Review 2.  PET versus SPECT: strengths, limitations and challenges.

Authors:  Arman Rahmim; Habib Zaidi
Journal:  Nucl Med Commun       Date:  2008-03       Impact factor: 1.690

3.  Primary malignant tumors of the sphenoidal sinus.

Authors:  F DeMonte; L E Ginsberg; G L Clayman
Journal:  Neurosurgery       Date:  2000-05       Impact factor: 4.654

4.  68Ga-DOTANOC PET/CT clinical impact in patients with neuroendocrine tumors.

Authors:  Valentina Ambrosini; Davide Campana; Lisa Bodei; Cristina Nanni; Paolo Castellucci; Vincenzo Allegri; Gian Carlo Montini; Paola Tomassetti; Giovanni Paganelli; Stefano Fanti
Journal:  J Nucl Med       Date:  2010-04-15       Impact factor: 10.057

Review 5.  Ectopic pituitary adenoma associated with an empty sella: a case report and review of the literature.

Authors:  Yoshikazu Kusano; Tetsuyoshi Horiuchi; Fusakazu Oya; Yoshinari Miyaoka; Kazuhiro Oguchi; Toshiki Takemae; Kazuhiro Hongo
Journal:  J Neuroimaging       Date:  2011-06-23       Impact factor: 2.486

Review 6.  Hereditary cancer predisposition syndromes.

Authors:  Judy E Garber; Kenneth Offit
Journal:  J Clin Oncol       Date:  2005-01-10       Impact factor: 44.544

7.  Screening for multiple endocrine neoplasia syndrome (type 1) in patients with primary hyperparathyroidism.

Authors:  C Muhr; S Ljunghall; G Akerstrom; M Palmér; K Bergström; P Enoksson; G Lundqvist; L Wide
Journal:  Clin Endocrinol (Oxf)       Date:  1984-02       Impact factor: 3.478

8.  Results of treatment of pituitary disease in multiple endocrine neoplasia, type I.

Authors:  T O'Brien; D S O'Riordan; H Gharib; B W Scheithauer; M J Ebersold; J A van Heerden
Journal:  Neurosurgery       Date:  1996-08       Impact factor: 4.654

9.  Sphenoid sinus ectopic pituitary adenomas: CT and MRI findings.

Authors:  B T Yang; V F H Chong; Z C Wang; J F Xian; Q H Chen
Journal:  Br J Radiol       Date:  2009-08-03       Impact factor: 3.039

Review 10.  Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature.

Authors:  Fathia Gibril; Michael Schumann; Andrea Pace; Robert T Jensen
Journal:  Medicine (Baltimore)       Date:  2004-01       Impact factor: 1.889
  10 in total
  6 in total

Review 1.  Metabolic In Vivo Visualization of Pituitary Adenomas: a Systematic Review of Imaging Modalities.

Authors:  Amy Yao; Priti Balchandani; Raj K Shrivastava
Journal:  World Neurosurg       Date:  2017-04-28       Impact factor: 2.104

Review 2.  Clinical and radiological presentation of parasellar ectopic pituitary adenomas: case series and systematic review of the literature.

Authors:  C Campana; F Nista; L Castelletti; M Caputo; E Lavezzi; P Marzullo; A Ferrero; G Gaggero; F R Canevari; D C Rossi; G Zona; A Lania; D Ferone; F Gatto
Journal:  J Endocrinol Invest       Date:  2022-02-11       Impact factor: 5.467

3.  Role of (68)Ga-DOTATATE PET/CT in patients with multiple endocrine neoplasia type 1 (MEN1).

Authors:  Secondo Lastoria; Francesca Marciello; Antongiulio Faggiano; Luigi Aloj; Corradina Caracò; Michela Aurilio; Laura D'Ambrosio; Francesca Di Gennaro; Valeria Ramundo; Luigi Camera; Leonardo De Luca; Rosa Fonti; Vincenzo Napolitano; Annamaria Colao
Journal:  Endocrine       Date:  2015-08-05       Impact factor: 3.633

4.  Secondary Hyperthyroidism due to an Ectopic Thyrotropin-Secreting Neuroendocrine Pituitary Tumor: A Case Report.

Authors:  Christian Trummer; Hannes Reiher; Verena Theiler-Schwetz; Marlene Pandis; Christian Gstettner; Peter Potzinger; Tilman Keck; Thomas R Pieber; Sigurd Lax; Johannes Haybaeck; Vinzenz Stepan; Stefan Pilz
Journal:  Eur Thyroid J       Date:  2020-01-21

Review 5.  PET/CT imaging of neuroendocrine tumors with (68)Gallium-labeled somatostatin analogues: An overview and single institutional experience from India.

Authors:  Punit Sharma; Harmandeep Singh; Chandrasekhar Bal; Rakesh Kumar
Journal:  Indian J Nucl Med       Date:  2014-01

6.  Incidental uptake of (18)F-fluorocholine (FCH) in the head or in the neck of patients with prostate cancer.

Authors:  Marina Hodolic; Virginie Huchet; Sona Balogova; Laure Michaud; Khaldoun Kerrou; Valérie Nataf; Marino Cimitan; Jure Fettich; Jean-Noël Talbot
Journal:  Radiol Oncol       Date:  2014-07-10       Impact factor: 2.991
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.